← Eichor
Study identifier: NCT06775964 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Stem Cell Therapy for Early Alzheimer's Disease

Condition: Cognitive Dysfunction  ·  Sponsor: Paul E Schulz

PhasePhase 1/Phase 2
Planned participants12
Who can joinAll sexes, 60 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given back to participants, so they are their own donor. The main questions this trial aims to answer are: * Does stem cell therapy reduce inflammation in the brain? * Does stem cell therapy improve brain activity? * Does stem cell therapy slow down progression to Alzheimer's disease? Participants will: * Have a small fat biopsy taken at a doctor's office to process stem cells * Receive 4 infusions of stem cells, through a vein in the arm over 12 weeks * Visit the clinic every 2-4 weeks for the first 4 months and then every 1-2 months for 8 months for checkups and tests

This description comes directly from the study's public registry record.

Talk to the study team

Harshali Patel  ·  713-486-0531  ·  Harshali.Patel@uth.tmc.edu

Javier Ortiz, PhD  ·  713-486-0505  ·  Guadalupe.J.Ortiz@uth.tmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas Health Science Center at Houston (UTHealth)Houston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06775964